Highlights Pfizer Limited

Equities

PFIZER

INE182A01018

Market Closed - NSE India S.E. Other stock markets 07:42:31 2024-04-30 am EDT			5-day change	1st Jan Change
4,257 ^INR	+1.36%		+2.54%	-0.28%

Apr. 02	Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	CI
Apr. 02	Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	Mar. 28	CI
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	23-10-30	MT
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-28	CI
Pfizer Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	23-08-21	CI
Seagen's breast cancer therapy meets main goal in late-stage study	23-08-16	RE
Pfizer Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Ex-dividend day for extraordinary dividend	23-08-10	FA
Final dividend	23-08-10	FA
Pfizer Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023	23-07-27	CI
Pfizer Limited Initiates Voluntary Recall Of Magnex 1gm, 2gm, Magnex Forte 1.5gm, 3gm, Zosyn 4.5gm and Magnamycin 250mg, 1gm, 2gm Injections	23-05-18	CI
Pfizer Posts Higher Fiscal Q4 Net Profit	23-05-16	MT
Pfizer's India unit posts 3% rise in Q4 profit	23-05-15	RE
Pfizer Limited Recommends A Final Dividend for the Financial Year Ended March 31, 2023, Payable on or Before September 16, 2023	23-05-15	CI
Pfizer Limited Recommends Special Dividend for the Financial Year Ended March 31, 2023, Payable on or Before September 16, 2023	23-05-15	CI
Pfizer Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
Pfizer Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-15	CI
Pfizer Completes Transfer of Thane, India Business to Vidhi Research	23-02-27	MT
Vidhi Research and Development LLP completed the acquisition of Thane Plant from Pfizer Limited.	23-02-23	CI
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pfizer Limited

Equities

PFIZER

INE182A01018

Highlights

Filters